Carmell (CTCX) Competitors $0.16 0.00 (-2.50%) As of 04/30/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CTCX vs. PETV, PSTV, PAVM, CODX, ICU, SSKN, ALUR, QTI, BTCY, and BSGMShould you be buying Carmell stock or one of its competitors? The main competitors of Carmell include PetVivo (PETV), Plus Therapeutics (PSTV), PAVmed (PAVM), Co-Diagnostics (CODX), SeaStar Medical (ICU), STRATA Skin Sciences (SSKN), Allurion Technologies (ALUR), QT Imaging (QTI), Biotricity (BTCY), and BioSig Technologies (BSGM). These companies are all part of the "medical equipment" industry. Carmell vs. PetVivo Plus Therapeutics PAVmed Co-Diagnostics SeaStar Medical STRATA Skin Sciences Allurion Technologies QT Imaging Biotricity BioSig Technologies Carmell (NASDAQ:CTCX) and PetVivo (NASDAQ:PETV) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, dividends, valuation, earnings, profitability, community ranking, risk, institutional ownership and media sentiment. Which has more volatility and risk, CTCX or PETV? Carmell has a beta of 0.51, indicating that its stock price is 49% less volatile than the S&P 500. Comparatively, PetVivo has a beta of 1.85, indicating that its stock price is 85% more volatile than the S&P 500. Do institutionals and insiders believe in CTCX or PETV? 24.2% of Carmell shares are owned by institutional investors. Comparatively, 24.5% of PetVivo shares are owned by institutional investors. 29.0% of Carmell shares are owned by company insiders. Comparatively, 10.8% of PetVivo shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the media refer more to CTCX or PETV? In the previous week, Carmell and Carmell both had 1 articles in the media. Carmell's average media sentiment score of 0.00 equaled PetVivo'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Carmell 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral PetVivo 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community prefer CTCX or PETV? Carmell and PetVivo both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformCarmellN/AN/APetVivoN/AN/A Which has better valuation and earnings, CTCX or PETV? PetVivo has higher revenue and earnings than Carmell. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCarmell$32.84K99.31-$15.44MN/AN/APetVivo$1.05M13.91-$10.95M-$0.45-1.34 Is CTCX or PETV more profitable? Carmell has a net margin of 0.00% compared to PetVivo's net margin of -902.82%. Carmell's return on equity of -217.50% beat PetVivo's return on equity.Company Net Margins Return on Equity Return on Assets CarmellN/A -217.50% -50.22% PetVivo -902.82%-4,813.07%-281.78% SummaryCarmell beats PetVivo on 5 of the 9 factors compared between the two stocks. Get Carmell News Delivered to You Automatically Sign up to receive the latest news and ratings for CTCX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CTCX vs. The Competition Export to ExcelMetricCarmellSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.26M$4.33B$5.53B$7.93BDividend YieldN/A39.93%5.11%4.22%P/E RatioN/A30.0322.5118.54Price / Sales99.3155.31397.62103.30Price / CashN/A51.0838.1834.62Price / Book0.156.056.734.25Net Income-$15.44M$68.71M$3.22B$248.18M7 Day Performance-2.50%-0.24%1.38%1.03%1 Month Performance23.71%-2.90%2.79%2.70%1 Year Performance-92.39%21.00%15.41%4.05% Carmell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CTCXCarmellN/A$0.16-2.5%N/A-92.4%$3.26M$32,839.000.0014PETVPetVivoN/A$0.50-3.8%N/A-24.9%$12.11M$1.05M-1.1120PSTVPlus Therapeutics2.4053 of 5 stars$0.70+9.2%$11.50+1,542.9%-62.2%$11.90M$4.91M-0.2820Positive NewsPAVMPAVmed4.4103 of 5 stars$0.68+3.0%$19.50+2,788.9%-64.5%$11.54M$3.00M-0.1690Short Interest ↓Gap UpCODXCo-Diagnostics4.3195 of 5 stars$0.34-4.0%$1.00+193.3%-69.3%$11.48M$3.92M-0.25100Upcoming EarningsGap UpICUSeaStar Medical0.6437 of 5 stars$1.27+5.3%N/A-88.8%$11.11M$135,000.00-0.112Short Interest ↓SSKNSTRATA Skin Sciences3.5167 of 5 stars$2.63-2.1%$6.00+128.6%-34.5%$10.95M$33.56M-0.99120Short Interest ↓Positive NewsALURAllurion Technologies3.4234 of 5 stars$2.24-2.1%$22.83+918.9%-96.0%$10.74M$32.11M-0.19501QTIQT ImagingN/A$0.67-5.0%N/A-6.8%$10.72M$4.00M0.00N/AUpcoming EarningsGap DownBTCYBiotricityN/A$0.43flatN/A-64.2%$10.71M$12.06M-0.4040Gap UpBSGMBioSig Technologies2.2614 of 5 stars$0.52-2.0%$2.50+377.1%-38.7%$9.03M$39,000.000.0050Positive News Related Companies and Tools Related Companies PETV Alternatives PSTV Alternatives PAVM Alternatives CODX Alternatives ICU Alternatives SSKN Alternatives ALUR Alternatives QTI Alternatives BTCY Alternatives BSGM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CTCX) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carmell Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Carmell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CTCX Stock Free CTCX Stock Alerts